HomeCompareCKHUY vs JNJ

CKHUY vs JNJ: Dividend Comparison 2026

CKHUY yields 2.94% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $9.2K in total portfolio value· pulled ahead in Year 6
10 years
CKHUY
CKHUY
● Live price
2.94%
Share price
$7.70
Annual div
$0.23
5Y div CAGR
-23.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$20.82
Full CKHUY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CKHUY vs JNJ

📍 JNJ pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCKHUYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CKHUY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CKHUY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CKHUY
Annual income on $10K today (after 15% tax)
$250.25/yr
After 10yr DRIP, annual income (after tax)
$17.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,968.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CKHUY + JNJ for your $10,000?

CKHUY: 50%JNJ: 50%
100% JNJ50/50100% CKHUY
Portfolio after 10yr
$25.7K
Annual income
$2,355.11/yr
Blended yield
9.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CKHUY
No analyst data
Altman Z
1.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CKHUY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCKHUYJNJ
Forward yield2.94%2.13%
Annual dividend / share$0.23$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-23.8%28%
Portfolio after 10y$21.1K$30.3K
Annual income after 10y$20.82$4,689.40
Total dividends collected$909.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CKHUY vs JNJ ($10,000, DRIP)

YearCKHUY PortfolioCKHUY Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,924$224.34$10,592$272.30+$332.00CKHUY
2$11,864$174.53$11,289$357.73+$575.00CKHUY
3$12,829$134.98$12,123$472.89+$706.00CKHUY
4$13,831$103.95$13,141$629.86+$690.00CKHUY
5$14,879$79.81$14,408$846.81+$471.00CKHUY
6← crossover$15,982$61.14$16,021$1,151.60$39.00JNJ
7$17,147$46.77$18,122$1,588.22$975.00JNJ
8$18,383$35.74$20,930$2,228.20$2.5KJNJ
9$19,697$27.28$24,792$3,191.91$5.1KJNJ
10$21,097$20.82$30,274$4,689.40$9.2KJNJ

CKHUY vs JNJ: Complete Analysis 2026

CKHUYStock

CK Hutchison Holdings Limited, an investment holding company, operates in ports and related services, retail, infrastructure, and telecommunications businesses worldwide. The company invests in, develops, and operates ports, which operate 291 berths in 52 ports spanning 26 countries; and provides logistics and transportation-related services, such as cruise ship terminals, distribution centers, rail services, and ship repair facilities. It also operates 12 retail brands with 16,398 stores that offer personal care, health and beauty products, food and fine wines, consumer electronics, and electrical appliances in Asia and Europe, as well as operates supermarkets; and manufactures and distributes bottled water and other beverages under the Watsons Water and Mr. Juicy brands in Hong Kong and Mainland China. In addition, the company invests in energy infrastructure, transportation infrastructure, water infrastructure, waste management, waste-to-energy, household infrastructure, and other infrastructure related businesses primarily in Hong Kong, Mainland China, the United Kingdom, Continental Europe, Australia, New Zealand, Canada, and the United States. Further, it provides mobile telecommunications and data services, as well as operates as an integrated energy company in the United States, Canada, and the Asia Pacific. Additionally, it researches, develops, manufactures, commercializes, markets, and sells nutraceuticals, pharmaceuticals, and agriculture-related products; provides marine construction and ship repair yard, water supply and sewerage, electricity generation and distribution, gas distribution, and aircraft maintenance services; and leases rolling stocks. CK Hutchison Holdings Limited was founded in 1828 and is based in Central, Hong Kong.

Full CKHUY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CKHUY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CKHUY vs SCHDCKHUY vs JEPICKHUY vs OCKHUY vs KOCKHUY vs MAINCKHUY vs ABBVCKHUY vs MRKCKHUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.